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IL-21 restricts T follicular regulatory T cell
proliferation through Bcl-6 mediated inhibition
of responsiveness to IL-2
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T follicular regulatory (Tfr) cells control the magnitude and specificity of the germinal centre
reaction, but how regulation is contained to ensure generation of high-affinity antibody is
unknown. Here we show that this balance is maintained by the reciprocal influence of
interleukin (IL)-2 and IL-21. The number of IL-2-dependent FoxP3þ regulatory T cells is
increased in the peripheral blood of human patients with loss-of-function mutations in the
IL-21 receptor (IL-21R). In mice, IL-21:IL-21R interactions influence the phenotype of
T follicular cells, reducing the expression of CXCR4 and inhibiting the expansion of Tfr cells
after T-cell-dependent immunization. The negative effect of IL-21 on Tfr cells in mice is cell
intrinsic and associated with decreased expression of the high affinity IL-2 receptor (CD25).
Bcl-6, expressed in abundance in Tfr cells, inhibits CD25 expression and IL-21-mediated
inhibition of CD25 is Bcl-6 dependent. These findings identify a mechanism by which IL-21
reinforces humoral immunity by restricting Tfr cell proliferation.
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C
ytokines provide cues that influence the growth, survival
and differentiation of immune cells. The cytokines
interleukin (IL)-2 and IL-21 are the products of
neighbouring genes on chromosome 3 in mice and chromosome
4 in humans. The Il2/Il21 locus has been associated with risk for
several autoimmune and inflammatory diseases in genome-wide
association studies1,2. Il2 and Il21 have similar intron and exon
structures, suggesting that these two genes arose by gene
duplication3,4. However, despite structural similarities, the gene
products IL-2 and IL-21 are growth and differentiation factors for
CD4þ T-cell subsets with distinct functions.
IL-2 is secreted by activated/effector T cells and is a survival
factor for Forkhead Box P3 (Foxp3)-expressing regulatory
T (Treg) cells, which are vital for regulating immune responses
in mice5–7. In humans, a severe autoimmune disease
immunodysregulation polyendocrinopathy enteropathy X-linked
syndrome results from inactivating mutations in FOXP3, leading
to dysfunction or deficiency in Treg cells8. The utilization of IL-2
by Treg cells is facilitated by binding of IL-2 by the cell surface
expressed a-chain of the heterotrimeric high-affinity IL-2
receptor, comprising the IL-2Ra chain (CD25), the IL-2Rb
chain (CD122) and the common g-chain (CD132)9.
The production of IL-21, in turn, is mostly restricted to
T follicular helper (Tfh) cells that provide help to B cells for the
generation of affinity-matured antibody during the germinal
centre (GC) reaction10,11. The receptor for IL-21 is closely related
to the IL-2Rb3,12 and is broadly expressed on haematopoietic
cells, where IL-21 imparts both autocrine and paracrine effects on
lymphocytes that influence survival and differentiation13–15.
In humans, loss-of-function mutations in IL21 or IL21R
cause a primary immunodeficiency syndrome associated
with an increased susceptibility to chronic infections and
gastrointestinal inflammation16–19. In addition to its roles in
immunity, IL-21 contributes to the development of inflammatory
and autoimmune diseases13.
Studies have revealed that IL-21-producing Tfh cells are
controlled by a subset of IL-2-dependent FoxP3-expressing
follicular Treg (Tfr) cells, a specialized subset of Foxp3þ
Treg cells that co-localize during GC reactions within B-cell
follicles20–22. FoxP3þ Tfr cells originate from natural (thymus-
derived) Treg cells and acquire features of Tfh cells, such as
expression of the B-follicular homing chemokine receptor CXCR5
(refs 20,23) and high expression of the co-inhibitory molecule
PD-1 (ref. 24). However, unlike Tfh cells, they lack expression
of CD40L, IL-4 and IL-21 (refs 20–22). Tfr cells are
suppressive and abrogating either Tfr cell development or their
follicular localization enhances the GC reaction and antibody
production20–22.
We have previously shown that Treg cells expand to a greater
extent in Il21 / mice than in IL-21-sufficient mice after
immunization and co-administration of anti-CD28 monoclonal
antibodies11 and more recent studies have shown that IL-21:
IL-21R signalling inhibits Treg expansion both in vitro25 and after
lymphocytic choriomeningitis virus (LCMV) infection26. IL-21 has
been shown to reduce FoxP3 expression, inhibit Treg suppressor
function and influence Treg homeostasis by decreasing IL-2
production from effector T cells in vitro25,27–31. By contrast, IL-2
inhibits Tfh cell differentiation through activation of STAT5 and
the subsequent repression of Bcl-6 (refs 32–35).
In this study, we provide evidence that IL-21 has the capacity
to reinforce the generation of a robust humoral immune response
by inhibiting the proliferation of Tfr cells.
Results
IL-21 inhibits Treg cells. We have previously shown that Treg
cell populations undergo greater expansion in Il21 / mice than
in IL-21-sufficient mice following administration of anti-CD28
monoclonal antibodies in conjunction with immunization with
the polyvalent antigen sheep red blood cells (SRBC)11. To further
analyse the influence of IL-21 on Treg cells, we used intracellular
immunostaining to distinguish total Foxp3þ CD4þ Treg and
FoxP3þ Tfr cells in Il21r / and wild-type (WT) mice
following immunization with SRBC.
The percentages of Tfh cells, defined as CXCR5hiPD-1hi CD4þ
T cells, in the spleen were similar in Il21r / and WT mice
7 days after immunization with SRBC (Fig. 1a,b and
Supplementary Fig. 1). By contrast, Il21r / Foxp3þ Tfr cells
within the CXCR5hiPD-1hi T follicular population were increased
in the spleen compared with WT Tfr cells in terms of both the
percentage (Fig. 1a,c) and absolute number of Tfr cells (Fig. 1d).
The effect of IL-21R on the T follicular cell populations resulted
in a significant (twofold) decrease in the Tfh:Tfr cell ratio
(Fig. 1e). Tfr cells derive from Treg cells20 and both subsets were
observed to express comparable amounts of the receptor for IL-21
(Supplementary Fig. 2). We similarly observed an increased
fraction of Il21r / total Foxp3þ Treg cells compared with
WT Treg cells following SRBC immunization (Fig. 1f). In contrast
to SRBC-immunized mice, the percentages of Treg cells in the
spleen of unmaniplated Il21r / and Il21rþ /þ mice were similar
(Fig. 1g). Thus, IL-21:IL-21R interactions, limit the expansion of
both total Treg cells and Tfrs following immunization.
To determine whether the increased fraction of Il21r / Tfr
cells and Treg cells was associated with increased proliferation of
these subsets, we immunostained for Ki67, which is a nuclear
protein associated with cellular proliferation. A greater percentage
of both Il21r / Treg cells (Fig. 1h) and Il21r / Tfr cells
(Fig. 1i) were observed to express Ki67 than their WT counter-
parts on day 7 of SRBC immunization. The populations of
FoxP3þ Treg cells and Tfr cells comprise both cells that express
the high-affinity receptor for IL-2 (identified by expression of the
a-chain of the IL-2R, CD25) and cells that lack CD25 (Fig. 1a). In
this regard, it was of interest to note that the Il21r / Ki67þ
proliferating Treg population contained a greater fraction of
CD25þ Treg cells relative to CD25 Treg cells than the
WT Ki67þ proliferating Treg population (Fig. 1j). This bias
was more evident in the proliferating Tfr cell population,
where CD25þ and CD25 Ki67þ Tfr cells were present in
equal ratios in Il21r / mice, whereas in WT mice, CD25þ Tfr
cells represented a minority of the Ki67þ population (Fig. 1k).
Previous studies have demonstrated that the expression of
CXCR5 on Treg cells depends upon the transcriptional repressor
Bcl-6 (ref. 21). Further analyses of the Tfr populations identified
increased expression of Bcl-6 in Tfr cells that lack CD25 when
compared with CD25þ Tfr cells (Fig. 1l,m). Furthermore,
CD25þ Tfr cells from Il21r / mice, despite exhibiting
increased proliferation, exhibited lower expression of Bcl-6
than WT CD25þ Tfr cells (Fig. 1m). Collectively, these findings
demonstrate that IL-21:IL-21R signalling reduces the prolifera-
tion of CD25-expressing Treg cells and Tfr cells, and indicate that
responsiveness to IL-2 is associated with reduced expression of
Bcl-6.
We next tested whether IL-21 had an influence on Treg
expansion in vitro. In the presence of anti-CD3 and anti-CD28
monoclonal antibodies alone, Il21r / CD4þ T-cell cultures
exhibited a greater fraction of FoxP3þ Treg cells compared with
WT CD4þ T-cell cultures (Fig. 1n and Supplementary Fig. 3).
Moreover, Il21r / CD4þ T cells cultured under polarizing
(transforming growth factor-b) conditions exhibited an approxi-
mately twofold greater expansion of Foxp3þ Treg cells when
compared with WT Treg cells cultured under the same conditions
(Fig. 1o). Taken together, these findings indicate that IL-21
inhibits Treg expansion both in vivo and in vitro.
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Figure 1 | IL-21 inhibits the proliferation of Foxp3þ Treg cells. Eight-week-old WT Il21rþ/þ and Il21r/ mice were immunized with 2 108 SRBC
intravenous and splenocytes were harvested on day 7 and stained for CD4, TCRb, CXCR5, PD-1 and CD25 surface markers, and intracellular Foxp3 for flow
cytometric analyses. (a) FACS dot plot shows gating strategy of CD4þ T cells for CXCR5þ PD-1þ Tfh cells and Foxp3þ CXCR5þ PD-1þ Tfr cells.
(b) Percentage of Tfh cells within the CD4þ T-cell population, (c) percentage of Foxp3þ Tfr cells within the CXCR5þ PD-1þ CD4þ T follicular population,
(d) absolute numbers of Tfr cells, (e) the ratio of Tfh cells to Tfr cells calculated per mouse and the percentages of Foxp3þ CD4þ Treg cells in (f) SRBC
immunized and (g) unimmunized mice. Values shown from individual mice, including means ±s.d. from three replicate experiments where n¼ 6–8 per
group. Percentage of proliferative cells in Il21r/ and WTmice on day 7 following SRBC immunization as determined by immunostaining for Ki67:
(h) Percentages of Ki67þ Treg cells. (i) Percentages of Ki67þ Tfr cells. (j) Ratio of CD25þ :CD25 cells within the Ki67þ Treg populations. (k) Ratio of
CD25þ :CD25 cells within the Ki67þ Tfr populations. (l) Representative FACS histogram overlays of Bcl-6 immunostaining in CD25þ and CD25 Tfr
populations and (m) quantification of the mean fluorescence intensity of Bcl-6 immunostaining in CD25þ and CD25 Tfr cells from Il21r/ and WT
mice 7 days after SRBC immunization. Values shown from individual mice, including means±s.d. from two replicate experiments. Statistical analyses were
performed by unpaired Student’s t-test, P-values 40.05 were deemed not significant (NS). Treg cell conversion efficiency was compared using splenic
CD4þ T cells from WT and Il21r/ mice. T cells were cultured with plate-bound anti-CD3 and soluble anti-CD28 monoclonal antibodies (n) and with
recombinant human transforming growth factor-b (TGFb) (o) and Treg cell conversion was assessed on day 3. Contour plots show CD4þ 7-AAD cells
and are representative of 4 independent experiments with similar results.
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Increased Foxp3þ T cells in IL-21R-deficient humans. In
humans, loss-of-function mutations in the IL21R gene cause a
primary immunodeficiency syndrome associated with recurrent
and chronic infections16,19. To determine whether Treg cells were
affected by IL-21R deficiency in humans, we analysed Treg cells
and Tfr-phenotype cells in the blood of three patients P1 (B.II-1,
a 13-year-old boy) and P2 (B.II-2, an 8-year-old boy), whose
lymphocytes have previously been shown to exhibit a loss of IL-
21-mediated signalling due to a homozygous deletion in exon 4 of
the IL21R gene16, and P3 (a 5-month-old sister of a previously
reported patient with the homozygous point mutation
c.G602A)19. Treg cells in the peripheral blood of the IL-21R-
deficient patients were compared with those in five age-matched
healthy control subjects.
Treg cells can be defined based on expression of CD4, CD25
and Foxp3. In humans, CD127 (IL-7Ra) is downregulated on
Foxp3þ CD4þ T cells, including those that express medium
levels of CD25 (refs 35,36). Treg cells, identified as
CD3þCD4þFoxp3þCD127lo were markedly increased in the
peripheral blood of all three IL-21R-deficient patients relative to
healthy control patients, shown as a percentage of CD4þ T cells
(Fig. 2a,b and Supplementary Fig. 4) and as a percentage of
peripheral blood lymphocytes (Fig. 2c). Similarly, CD25þ
FoxP3þCD3þCD4þ Treg cells were increased within CD4þ
T-cell populations (Fig. 2d) and total lymphocyte populations
(Fig. 2e) of all three IL-21R-deficient patients compared with
healthy controls.
FoxP3-expressing CD4þ T cells that exhibit a Tfr phenotype
have previously been detected in the peripheral blood of mice37.
Circulating and lymph node resident Tfr cells shared properties
of memory cells, but blood Tfr cells were found to exhibit a
relatively reduced suppressive capacity compared with lymphoid
tissue-derived Tfr cells38. When we analysed follicular T-cell
populations in the peripheral blood of the three IL-21R-deficient
patients, we observed that the fractions of circulating
CD4þCXCR5hiPD-1hiFoxp3 Tfh phenotype cells were within
the broad range of healthy controls (Fig. 2f), which is consistent
with previous observations19,39. By contrast, the percentages of
CD4þCXCR5hiPD-1hiCD127loFoxp3þ Tfr phenotype cells in
the peripheral blood of IL-21R-deficient patients were elevated
relative to healthy controls (Fig. 2g). Thus, FoxP3þ total Treg
cells and Tfr cells are increased in the blood of humans with
loss-of-function mutations in the IL-21R and the expansion or
increase in Treg cells occurs very early in life.
IL-21:IL-21R signalling reduces CXCR4 on Tfh cells. Tfh cells
were observed in similar percentages in the presence and absence
of IL-21R in humans and in mice following T-dependent
immunization. Previous studies have shown that IL-6 can act
redundantly to support Tfh cell differentiation in Il21r /
mice40,41. However, whether Il21r / and WT Tfh cell
populations are phenotypically distinct remains largely
unexplored. C-X-C chemokine receptor type 4 (CXCR4) is a
chemokine receptor expressed on T-extrafollicular helper cells42
and is also expressed on a fraction of Tfh cells43,44. Analyses of
CXCR4þ PD-1hi CD4þ Th cells on day 7 of SRBC-immunized
Il21r / and WT mice demonstrated that IL-21 significantly
limits the expression of CXCR4 and the expansion of CXCR4þ
PD-1hi T cells (Fig. 3a). The percentages of Il21r / CXCR4þ
CXCR5 PD-1hi FoxP3 Tfh cells were notably increased
relative to WT extrafollicular T-helper cells (Fig. 3a,b).
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Figure 2 | IL-21 limits Treg cells in humans. Analyses of CD4þ T cells in peripheral blood of human patients with loss of function mutation in IL21R
compared with control patients. (a) Representative flow cytometry dot plots of peripheral blood from a healthy donor and an IL-21R-deficient patient
(B.II-2) showing CD4þ CD3þ Tcells immunostained for surface IL-7Ra (CD127) and nuclear Foxp3. Foxp3þ CD127lo Treg cells are shown as percentage
of CD4þ T cells (b) and as a percentage of lymphocytes (c) in three IL-21R-deficient patients compared with five healthy controls. FoxP3þ CD25þ
Treg cells shown as a percentage of CD4þ Tcells (d) and as a percentage of lymphocytes (e) in three IL-21R-deficient patients compared with five healthy
controls. Data are shown for individual patients with means ±s.d. FoxP3CXCR5þPD-1þ CD4þ Tfh cells (f) and Foxp3þCXCRþPD-1þ Tfr cells as a
percentage of CXCR5þPD-1þCD4þCD3þ T cells (g) from peripheral blood of IL-21R-deficient patients and healthy controls shown as individual values
with means ±s.d. P-values were determined by Student’s t-test, P-values 40.05 were deemed not significant (NS).
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Interestingly, we also observed a fraction of previously
undescribed CXCR4þ extrafollicular Treg cells (CXCR4þ
CXCR5 PD-1hi FoxP3þ CD4þ T cells) in both Il21r /
and WT mice (Fig. 3a,c).
When we focused on Tfh cells, we observed that CXCR4
distinguished Il21r / Tfh cells from WT Tfh cells. Il21r /
Tfh cells had an increased propensity to co-express CXCR4
(Fig. 3d) and IL-21:IL-21R interactions significantly reduced the
expression of CXCR4 on Tfh cells (Fig. 3e,f). Interestingly, we
observed a similar theme for Tfr cells 7 days after SRBC
immunization, with increased percentages of CXCR4 expressing
Il21r / Tfr cells compared with WT Tfr cells (Fig. 3g). The
intensity of CXCR4 expressed on the surface of Il21r / Tfr was
also significantly increased (Fig. 3h,i). These findings demonstrate
that IL-21:IL-21R interactions influence the phenotype of
follicular T-cell populations by restricting CXCR4-expressing
Tfh and Tfr cells, and the intensity of expression of CXCR4.
In stark contrast to Th cells, CXCR4-expressing GC B cells
were decreased in the absence of IL-21:IL-21R interactions.
CXCR4-expressing GC B cells, a phenotype consistent with
centroblasts45, were reduced in Il21r / mice on day 7 following
SRBC immunization and the intensity of CXCR4 expression was
similarly decreased on Il21r / GC B cells (Supplementary
Fig. 5). Moreover, the reduced fraction of CXCR4 expressing cells
and intensity of CXCR4 expression was specific to GC B cells,
since the percentage of CXCR4þ cells and the intensity of
CXCR4 were similar on the total Il21r / and WT B cell
populations (Supplementary Fig. 5).
IL-21R intrinsic reduction of Tfr cells. The above findings
indicated that IL-21 alters the phenotype of T follicular cells, but
did not explain the marked expansion of Tfr cells in Il21r /
mice. To determine whether IL-21:IL-21R interactions had a cell
intrinsic contribution to Treg cell subsets, we examined total Treg
cells and Tfr cells during GC reactions that form following
immunization in mixed bone marrow (BM) chimeras in mice
consisting of WT BM expressing the congenic marker Thy1.1 and
either Il21r / Thy1.2 BM or control WT Thy1.2 BM delivered
at 1:1 ratios into irradiated WT CD45.1 recipients. The host
CD45.1 congenic marker enabled exclusion of host radioresistant
T cells, which typically constitute 10% of the total T cells.
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Figure 3 | IL-21:IL-21R interactions reduce CXCR4 expression on Tfh cells. Eight-week-old WT Il21rþ/þ and Il21r/ mice were immunized with 2 108
SRBC (intravenous). On day 7, splenocytes were harvested and stained for CD4, TCRb, CXCR5, PD-1 and CXCR4 surface markers and intracellular Foxp3.
(a) Representative FACS dot plots showing expression of CXCR4 and CXCR5 on PD-1hi, PD-1hi Foxp3 and PD-1hi Foxp3þ CD4þ Tcells. (b) Percentages
of CXCR4þ CXCR5PD-1hi Foxp3 CD4þ extrafollicular T helper cells and (c) CXCR4þ CXCR5PD-1hi Foxp3 CD4þ extrafollicular Treg cells in WT
and Il21r/ mice. Percentages of (d) CXCR4 expressing Tfh cells (CXCR5hi PD-1hi FoxP3 CD4þ Tcells), (e) the mean fluorescence intensity (MFI) of
CXCR4 expression on Tfh cells shown as a histogram overlay where WT Tfh cells are shown as a filled histogram and Il21r/ Tfh cells are shown as a
black line, and (f) quantification of MFI of CXCR4 on WTand Il21r/ Tfh cells. Percentages of (g) CXCR4 expressing Tfr cells (CXCR5hi PD-1hi FoxP3þ
CD4þ Tcells) and the mean fluorescence intensity (MFI) of CXCR4 surface expression on WTand Il21r/ Tfr cells shown as (h) a histogram overlay and
(i) quantification of MFI of CXCR4 on WTand Il21r/ Tfr cells. Data are shown from one representative experiment as individual mice and means±s.d.,
from two experimental replicates with similar results. P-values were determined by Student’s t-test, P-values 40.05 were deemed not significant (NS).
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Eight weeks later, and after checking chimerism following
reconstitution, mice were immunized with SRBC and the relative
contribution of WT and Il21r / T cells to the percentages of
follicular T cells and Treg cells were determined.
Control chimeras consisting of 50% WT Thy1.1 BM and 50%
WT Thy1.2 BM exhibited similar contributions of each congenic
marker to the total CD4þ T cell (Fig. 4a–c and Supplementary
Fig. 6), Tfh cell (Fig. 4a), Treg (Fig. 4b) and Tfr cell (Fig. 4c)
populations. For chimeras consisting of 50% WT Thy1.1 BM and
50% Il21r / Thy1.2 BM, equal fractions (50%:50%) of Thy1.1
WT and Thy1.2 Il21r / lymphocytes were detected in blood
before immunization (Fig. 4d). However, following immunization
with SRBC, B39% of CD4þ T cells in the spleen were derived
from Thy1.2 Il21r / (Fig. 4e). CXCR5hiPD-1hiFoxp3CD4þ
TCRbþ Tfh cells exhibited similar proportions as total CD4þ
T cells, with a slightly decreased fraction of Thy1.2þ Il21r /
Tfh cells (mean of 34.8% of the total donor CD45.2þ Tfh cells)
derived from the Thy1.2þ Il21r / CD4þ T-cell donor
population (mean of 39% of CD45.2 CD4þ T cells) in each
mouse (Fig. 4e). Similarly, there was only a small cell intrinsic
contribution of IL-21R expression on Treg cells, with a slightly
greater increase in Thy1.2 Il21r / Treg cells (44.3%) relative to
Thy1.2 Il21r / CD4þ T cells (39%) within the total CD45.2þ
CD4þ T-cell donor population of each mouse (Fig. 3f). By
contrast, B39% of Il21r / CD4þ T cells contributed 54% of
the total CD45.2þ Tfr cell population, whereas 61% of WT
Thy1.1þCD4þ T cells contributed only 46% of the total Tfr cells,
demonstrating an increased conversion of Il21r / cells to the
Tfr phenotype relative to WT cells (Fig. 4g).
Parallel analyses of the T-cell subsets within each donor
population showed that the fractions of Il21r / and WT Tfh
cells were similar, with a minor decrease in Il21r / Tfh cells
compared with WT Tfh cells observed (Fig. 4h). Similarly,
Il21r / Treg cells were observed at slightly higher percentages
compared with WT Treg cells (Fig. 4i). By contrast, there was a
markedly greater percentage of Il21r / Foxp3þ Tfr cells
compared with WT Tfr cells (Fig. 4j). The increased fraction of
Il21r / Tfr cells resulted in a twofold decrease in the overall
ratio of Tfh:Tfr Il21r / cells compared with WT cells (Fig. 4k).
Detection of Foxp3þ cells in histological sections of the spleen in
mixed BM chimeras identified both Thy1.1 WT and Thy1.2
Il21r / Tfr cells within the IgDlo GC areas (Fig. 4l).
Enumeration of Foxp3þ Thy1.1þ and Thy1.2þ GC cells
revealed that Il21r / Thy1.2þ Tfr cells comprising a
significantly greater percentage of the total GC Foxp3þ
population (Fig. 4m). Taken together, these findings demon-
strated that the cell-intrinsic effect of IL-21R was conspicuous for
Tfr cells, but not for total Treg cells.
IL-21 reduces expression of CD25 and responsiveness to IL-2.
In addition to the analyses of the relative proportions of WT and
Il21r / CD4þ T-cell subsets in the SRBC-immunized mixed
BM chimeras, we measured expression of IL-2Ra (CD25), which
closely aligns with the Foxp3þ Treg population in mice. Treg
cells in SRBC-immunized Il21r / :WT mixed BM chimeras
demonstrated increased percentages of both CD25 Il21r /
Treg cells (Fig. 5a,b) and CD25þ Il21r / Treg cells (Fig. 5a,c)
compared with WT Treg cells. However, equivalent high
expression levels of CD25 were observed on WT and Il21r /
Foxp3-expressing (non-follicular) Treg cells (Fig. 5d). By con-
trast, we observed equivalent percentages of CD25 Tfr
cells derived from Il21r / and WT BM (Fig. 5e,f), but the
percentages of Il21r / CD25þ Tfr cells were over twofold
greater than WT CD25þ Tfr cells (Fig. 5e,g). These data indicate
that within the same recipient mice, IL-21 modulated the
expression of CD25 on Tfr cells, but not on the non-follicular
Treg population. Furthermore, an expansion of Il21r / Treg
cells was observed in both the CD25þ and CD25 populations,
whereas the increased fraction of Il21r / Tfr cells were
predominantly those that expressed CD25.
Tfr cells are derived from Treg cells, but exhibited lower
expression of CD25 (Fig. 5d,h). It was of interest to observe that
in the absence of IL-21R, CD25 expression levels on Tfr cells
approximated that of their Treg precursors (Fig. 5h). Given that
Tfrs derive from Treg cells, this finding suggested that in mixed
BM chimeras with presumably equivalent IL-2 bioavailability, the
expression of CD25 on Tfr cells was reduced by IL-21 in a cell
intrinsic manner. Taken together, these data show a more marked
effect of IL-21 on Tfr cells, and that the relatively mild effect of
IL-21 on CD25 expression on non-follicular Treg cells correlates
with these cells already having maximum high CD25 expression.
Therefore, our findings are consistent with an ability of
IL-21:IL-21R signalling to limit responsiveness to IL-2.
As the expression of CD25 influences receptiveness to IL-2, we
argued that Il21r / Tfr cells should be more responsive to IL-2
than WT Tfr cells. To test this possibility, we administered
IL-2:IL-2mAb complexes46 to SRBC-immunized Il21r / and
WT mice, to drive the expansion of CD25-expressing cells that
occurs following SRBC immunization. A greater percentage of
Il21r / Treg cells than WT Treg cells was observed after
IL-2:IL-2mAb administration (Fig. 5i). However, the fold increase
in IL-2:IL-2mAb expanded Treg cells relative to Treg cells in
control SRBC-immunized mice just reached significance (Fig. 5j).
Consistent with the effect of the IL-2:IL-2mAb complexes on
expansion of Treg cells, the percentage of Il21r / Tfr cells was
significantly greater than that of WT Tfr cells after IL-2:IL-2mAb
treatment (Fig. 5k). However, in contrast to the Treg population,
IL-2:IL-2mAb treatment induced a significantly greater expansion
of Il21r / Tfr cells, shown as an increase in the fold change
above SRBC-immunized mice (Fig. 5l). Thus, Foxp3þCD4þ
T cells expanded more efficiently in the absence of IL-21:IL-21R
signalling and this was most pronounced in the Tfr population.
The increased expansion in response to an excess of exogenous
IL-2 by Il21r / Tfr cells was associated with increased surface
expression of CD25, the high-affinity IL-2 receptor. However, this
relationship was not evident in the IL-2-dependent non-follicular
Treg population, where CD25 was expressed similarly and at the
highest levels on both WT and Il21r / Treg cells.
A central function of STAT5 in T cells is to mediate signalling
by IL-2. As there was no obvious difference in the level of
expression of CD25 on the large non-follicular Treg population,
we further tested whether the deficiency of IL-21R influenced
Treg responsiveness to IL-2 by measurement of rmIL-2-induced
phosphorylation of STAT5 by immunostaining and flow
cytometry. Both WT and Il21r / CD25þ Foxp3þ Treg cells
exhibited increased STAT5 phosphorylation after 15min of
stimulation with rmIL-2 (Supplementary Fig. 7). However,
Il21r / cells exhibited increased pSTAT5 intensity and an
increased percentage of Foxp3þ Treg cells containing pSTAT5
compared with WT cells in response to the same titration of
rmIL-2 (Supplementary Fig. 2). Inclusion of exogenous rmIL-21
had no effect on rmIL-2-mediated phosphorylation of STAT5
in WT cells (Supplementary Fig. 2). This finding indicated
that Il21r / Treg cells were preconditioned for heightened
signalling in response to IL-2.
Bcl-6 inhibits CD25 expression on CD4þ T cells. We were
intrigued that IL-21:IL-21R signalling had a more pronounced
cell intrinsic effect on Tfr cells than Treg cells. As discussed
earlier, Tfr cells derive from Treg precursors and upregulate Bcl-6
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Figure 4 | IL-21 has a cell intrinsic contribution to Tfr cell inhibition. Mixed BM chimeras were generated by reconstituting lethally irradiated 8-week-old
CD45.1 recipients with 5 106 each of CD45.2 BM cells from either Il21rþ/þThy1.1þ and Il21r/Thy1.2þ or control chimeras consisting of BM from
Il21rþ/þThy1.1þ and Il21rþ/þ Thy1.2 mice. Eight weeks after BM transfer, mice were immunized intravenously with 2 108 SRBC and the CD4þ T-cell
populations in the spleen were assessed on day 7. (a) Control chimeras showing relative percentages of Thy1.1 and Thy1.2 CD4þ T cells within the total
CD45.2 CD4þ T cell population. (b) Relative percentages of Thy1.1 and Thy1.2 Foxp3þ Treg cells and (c) Thy1.1 and Thy1.2 Foxp3þCXCR5þPD-1þ Tfr
cells within the donor CD45.2 populations, respectively. (d) Chimerism was assessed by tail bleed at 7 weeks. (e) Relative percentages of Thy1.2 Il21r/
CD4þ T cells within the total CD45.2 CD4þ T-cell population (shown in e–g) and Thy1.2 CXCR5þPD-1þ Foxp3 Tfh cells. (e) Relative percentages of
Thy1.2 Foxp3þ Treg cells. (f) Relative percentages of Thy1.2 Foxp3þ Treg cells and (g) relative percentages Thy1.2 Foxp3þ CXCR5þ PD-1þ CD4þ Tfr
cells within the total CD45.2 Tfr population. Percentages of (h) Tfh cells as a percentage of CD4þ T cells. (i) Treg cells as a percentage of CD4þ T cells.
(j) Tfr cells as a percentage of CXCR5þ PD-1þ CD4þ T follicular cells and (k) the ratio of Tfr:Tfh in individual mice within the Thy1.1 Il21rþ/þ and
Thy1.2 Il21r/ CD4þ donor populations in chimeras. Data are shown as individual mice n¼ 5 from two separate experiments with similar results.
Statistical analyses were performed by paired Student’s t-test, P-values 40.05 were deemed not significant. Localization of Thy1.1 (WT) Il21rþ/þ and
Thy1.2 Il21r/ Foxp3þ cells within GCs of the spleen from mixed BM chimeras: GCs were identified as IgDlo. (l) Tfr cells within the GCs were identified
with Foxp3 (red), Thy1.1 (blue) and Thy1.2 (green). Individual antibody immunostains are shown in grey scale. Scale bars, 100mm. (m) Quantification of the
percentage of Tfr cells counted from 80 immunostained GCs in sections of spleen as in k. Data are shown as mean ±s.d., n¼ 5 mice.
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and CXCR5 (which is dependent upon Bcl-6)47, enabling their
follicular localization. Therefore, we next determined whether
IL-21 influenced CD25 expression directly and whether Bcl-6
mediated the effects of IL-21 on CD25 expression.
We first determined whether blockade of IL-21:IL-21R in vitro
could mimic the increased expression of CD25 observed on
Il21r / CD4þ T cells. Culture of CD4þ T cells stimulated
with soluble anti-CD3 monoclonal antibody and decreasing doses
of soluble anti-CD28 monoclonal antibody over 3 days in
the presence of IL-21-neutralizing IL-21RFc increased CD25
expression on both the total CD4þ T-cell population (Fig. 6a and
Supplementary Fig. 7) and the Foxp3 CD4þ T-cell population
at lower doses of CD28 (o0.25 mgml 1) (Fig. 6b and
Supplementary Fig. 7). In contrast to the Foxp3 CD4þ T-cell
population, the intensity of CD25 expression on Foxp3þ Treg
cells was not changed by IL-21 neutralization (Fig. 6c and
Supplementary Fig. 7). The increased intensity of CD25
expression could be accounted for by an increased percentage
of cells expressing high levels of CD25 on both the total CD4þ
T-cell population (Fig. 6d) and the Foxp3 population (Fig. 6e).
By contrast, but consistent with the intensity of CD25 expression
of Treg cells, the fraction of CD25-expressing Treg cells did not
improve with the addition of IL-21RFc over the 3-day culture
(Fig. 6f). Thus, neutralization of IL-21 improved responsiveness
to IL-2 in CD4þ T cells and this was particularly evident under
conditions of limiting co-stimulation by anti-CD28 monoclonal
antibodies.
IL-21 modulates CD25 expression via Bcl-6. IL-21 can upre-
gulate the expression of Bcl-6 in CD4þ T cells48. To determine
whether Bcl-6 mediated the effects of IL-21 on CD25 expression,
we analysed the influence of IL-21 on CD25 expression on both
CD4þ T cells and CD4þ T cells deficient in Bcl-6 in vitro.
CD4þ T cells lacking Bcl-6 (CD4Cre/WT:BCL6fl/fl) exhibited
increased expression of CD25 (Fig. 6g) and increased percentages
of CD4þ T cells expressing high amounts of CD25 (Fig. 6h) in
response to stimulation with anti-CD3 monoclonal antibody in
the presence of anti-CD28 monoclonal antibody. There was a
consistent trend of modulation of CD25 by IL-21 on WT (WT/
WT:BCL6fl/fl) CD4þ T cells: when shown as fold change relative
to the mean of CD3 monoclonal antibody and CD28 monoclonal
antibody alone, the intensity of CD25 expression (Fig. 6i) and the
percentages of CD25hi CD4þ T cells (Fig. 6j) were reduced in the
presence of exogenous rmIL-21 compared with IL-21RFc.
However, IL-21RFc did not efficiently upregulate CD25 or
increase CD25hi CD4þ T cells in the presence of an excess of
exogenous rmIL-21 (Fig. 6i,j, respectively). It was of interest to
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Figure 5 | IL-21 limits responsiveness to IL-2. A direct comparison of CD25 expression on Thy1.1 Il21rþ/þ cells and Thy1.2 Il21r/ Treg populations
from mixed BM chimeras described in Fig. 4. (a) Representative FACS dot plot showing CD25 and Foxp3 expression in CD4þ Tcells. Relative percentages
of Thy1.1 Il21rþ/þ cells and Thy1.2 Il21r/ cells in individual mice showing Foxp3þ CD4þ T cells that either (b) lack CD25 expression or (c) express
CD25. (d) MFI of CD25 on Thy1.1 Il21rþ/þ cells and Thy1.2 Il21r/ Foxp3þ CD4þ T cells. (e) Representative FACS dot plot showing CD25 and Foxp3
expression in CXCR5þ PD-1þ CD4þ Tcells. Relative percentages of Thy1.1 Il21rþ/þ cells and Thy1.2 Il21r/ Foxp3þ Tfr cells that either (f) lack CD25
expression or (g) express CD25. (h) MFI of CD25 on Thy1.1 Il21rþ/þ cells and Thy1.2 Il21r/ Foxp3þ Tfr cells. IL-2:IL-2mAb complex expansion of Treg
cells in Il21r/ and WT C57BL/6 mice: (i) Quantification of Foxp3þCD25þ Treg cells as a proportion of CD4þTCRbþ T cells in IL2:IL2 monoclonal
antibody-injected mice and (j) fold increase of Treg cells in response to IL2:IL2 monoclonal antibody treatment relative to SRBC immunized alone.
(k) Quantification of Foxp3þ Tfr cells as a proportion of CXCR5þPD-1þCD4þTCRbþ T cells and (l) fold increase of Tfr cells on IL2:IL2 monoclonal
antibody treatment. Data are shown as individual mice with means±s.d., from two replicate experiments, P-values were determined by Student’s t-test,
P-values 40.05 were deemed not significant (NS).
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Figure 6 | Bcl-6 inhibits CD25 and IL-21 modulates CD25 through Bcl-6. CD4þ T cells from the spleen of C57BL/6 mice were cultured ex vivo in the
presence of anti-CD3 monoclonal antibody and decreasing concentrations of anti-CD28 monoclonal antibody, in the presence or absence of IL-21
neutralization (IL-21RFc) for 3 days. Bar graphs showing the immunofluorescence intensity (MFI) of the expression of CD25 on (a) TCRbþCD4þ T cells
(b) Foxp3 TCRbþCD4þ Tcells and (c) Foxp3þ TCRbþCD4þ Tcells in the presence (grey bars) or absence (black bars) of 5 mgml 1 of IL-21RFc. The
percentages of CD25-expressing (d) TCRbþCD4þ Tcells, (e) Foxp3 TCRbþCD4þ Tcells and (f) Foxp3þTCRbþCD4þ Tcells. Data are shown as the
means ±s.d. of triplicate samples from a representative of two experiments with similar results. P-values were calculated by Student’s t-test where
*Po0.05. Bcl-6 inhibits CD25 expression on CD4þ Tcells: CD4þ Tcells were purified from mice in which Bcl-6 was conditionally deleted in CD4þ Tcells
(CD4Cre/WT:BCL6fl/fl) and Bcl-6-sufficient littermates (CD4WT/WT:BCL6fl/fl). Quantification of (g) the mean fluorescence intensity (MFI) of CD25 and
(h) percentage of cells expressing high amounts of CD25 in Bcl6-sufficient (black bars) and Bcl6-deficient (grey bars) CD4þ T cells cultured in the
presence of soluble anti-CD3 and anti-CD28 monoclonal antibodies and in the presence or absence of recombinant murine IL-21 and IL-21RFc. (i) Fold
change of MFI relative to the mean value (dotted line) of CD4þ T cells stimulated with anti-CD3 and anti-CD28 monoclonal antibodies alone and
(j) percentages of CD25-expressing CD4þ Tcells. CD4þ T cells stimulated with anti-CD3 showing (k) fold change from the mean MFI (dotted line) and
(l) percentages of CD25-expressing cells. Data are shown as the means±s.d. of triplicate samples from a representative of two experiments with similar
results. P-values were determined by one-way analysis of variance where significant differences between groups are shown as *Po0.05 and **Po0.01.
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observe that IL-21 had a greater inhibitory effect on the intensity
of CD25 expression and the percentages of CD25hi CD4þ T cells
in cultures stimulated with anti-CD3 monoclonal antibodies
alone (Fig. 6k,l, respectively). Conversely, in the absence of CD28
costimulation, IL-21RFc neutralization was less effective at
modulating CD25 expression (Fig. 6k,l). The ability of IL-21 to
modulate CD25 expression was dependent upon expression
of Bcl-6 in CD4þ T cells, as neither the intensity of CD25 on Bcl-
6-deficient CD4þ (Cre/WT:BCL6fl/fl) T cells (Fig. 6g–i) nor the
percentages of CD25hi Bcl-6-deficient CD4þ T cells (Fig. 6j–l)
were different either in the presence or absence of IL-21 or
IL-21RFc. Taken together, these findings demonstrate that Bcl-6
inhibits CD25 expression on CD4þ T cells, and that IL-21 can
limit the magnitude of CD25 expression and CD25-expressing
CD4þ T cells through Bcl-6.
IL-21 acts on Treg cells to modulate GC output. To determine
whether IL-21R expression on Treg cells had functional con-
sequences in terms of GC output, we performed adoptive transfer
of IL-21R-deficient (Il21r / ) and IL-21R-sufficient (WT) Treg
cells into Treg-deficient recipients. FoxP3DTR-recipient mice were
treated with diphtheria toxin to remove endogenous Treg cells,
before transfer of Il21r / or WT Treg cells and immunization
with 4-hydroxy-3-nitrophenyl acetyl-hapten (NP)-OVA adsorbed
to alum. We immunized with NP-OVA to enable the identifica-
tion of antigen (NP)-specific B cells. On day 10 of immunization,
the spleens of recipient mice were analysed histologically showing
localization of both Il21r / Tfr cells (Fig. 7a) and WT Tfr cells
(Fig. 7b) to the GC of FoxP3DTR recipients.
Immunostaining and flow cytometric analyses on day 10 of
NP-OVA immunization demonstrated similar percentages
of Treg cells from Il21r / and WT donors (Fig. 7c and
Supplementary Fig. 7 for gating strategy), as well as efficient
depletion of endogenous FoxP3þ CD4þ Treg cells by diphtheria
toxin administration in mice that did not receive exogenous Treg
cells (Fig. 7c). By contrast, Foxp3DTR recipients of Il21r / Treg
cells contained a greater fraction of Tfr cells compared with
recipients of WT Treg cells (Fig. 7d) and a greater fraction of
Il21r / Tfr cells expressed CD25 (Fig. 7e). CXCR4 was
increased on Tfr cells in the absence of IL-21:IL-21R interactions
(Fig. 4), but was not significantly different on Tfr cells from either
donor genotype in FoxP3DTR recipients (Fig. 7f). By contrast,
the percentages of CXCR5hi Bcl-6hi Tfh cells were slightly
decreased in recipients of Il21r / Treg cells (Fig. 7g). Thus,
Il21r / Tfr cells derived from adoptively transferred Il21r /
Treg cells and expand to a greater extent than WT Tfr cells, and
this finding is consistent with our observations of the behaviour
of Il21r / Tfr cells in mixed BM chimeras (Fig. 4).
Analysis of the effect of Il21r / and WT Treg transfer on the
GC B-cell population showed equivalent percentages of GC B cells
in FoxP3DTR recipients of Il21r / and WT Treg cells (Fig. 7h
and Supplementary Fig. 8). However, a closer examination of the
GC B-cell population revealed that recipients of Il21r / Treg
cells harboured reduced percentages of IgG1þ GC B cells (Fig. 7i),
with a relative reduction of IgG1þ cells within the total GC B-cell
population (Fig. 7j). Furthermore, FoxP3DTR recipients of Il21r /
 Treg cells had slightly reduced percentages of NP-specific GC B
cells (Fig. 7k,l) and, in keeping with the reduced IgG1þ GC B cell
population, reduced percentages of IgG1þ NP-specific GC B cells
(Fig. 7m). These data suggest that the increased percentages of
Il21r / Tfr cells had the functional effect of reducing the
percentages of IgG1þ GC B cells.
Discussion
The discovery of Treg cells that function within the B-cell follicle
provided evidence that regulation of antibody production occurs
within the GC niche20–22. Our study provides insights into how
the interplay between two neighboring genes, namely Il2 and Il21,
can shape antibody responses. IL-21 activates the Jak–STAT
signalling pathway, leading to phosphorylation of STAT1 and
STAT3, whereas IL-2 strongly activates STAT5. The ability of
different STAT molecules to compete for STAT binding sites and
affect gene transcription may underpin the relative influence of
IL-2 and IL-21 on Tfh and regulatory subsets31–34,49. The relative
influence of IL-2 and IL-21 on T follicular cells is likely to be
dictated by several factors including the localization of cytokine
production within the T-cell areas and B-cell follicles of
secondary lymphoid organs50,51.
Both total FoxP3þ Treg cells and Tfr-phenotype cells were
increased in the blood of IL-21R-deficient humans, suggesting
that IL-21:IL-21R signalling has a negative influence on human
Treg cells. CD25hi CD4þ T cells in peripheral blood were
previously shown to be similar between IL-21R-deficient patients
and healthy controls19,39, and our findings are consistent with
these observations. By contrast, dual expressing FoxP3þCD25hi
Treg cells were increased by IL21R deficiency. We also identified
an increase in the fraction of Tfr-phenotype cells in peripheral
blood, but the relationship of these cells with Tfr cells described
in secondary lymphoid organs remains unknown. The initial
study describing immune dysregulation in IL-21R defective
patients reported that they exhibit recurrent and chronic
infections16. Suppression of the immune response to infection
by Treg cells in humans has been suggested previously. For
instance, in HIV infection, the Foxp3þCD127lo CD4þ T-cell
population may be particularly important in limiting immune
activation52. The increase in Treg cells and Tfr-phenotype cells in
IL-21R-defective patients is a remarkable finding, but whether the
expanded population of Treg cells contributes to the inability to
control chronic infection in these patients remains unknown.
In mice, the cell-intrinsic effect of IL-21R was more
conspicuous for the follicular subset of Foxp3þ T cells than for
the broader Treg population. Previous studies have demonstrated
that IL-21 has direct negative effects on Treg cells and can
destabilize FoxP3 expression27–30,53. IL-21 can inhibit both Treg
expansion following LCMV infection in a cell intrinsic manner26
and Foxp3þCXCR5þ ICOSþCD4þ cells in autoimmune BXD2
mice54. In addition, another recent study demonstrated that IL-21
limits Treg cells in a cell extrinsic manner by inhibiting IL-2
production from conventional T cells in vitro25 and our findings
are consistent with IL-2 or other extrinsic factors contributing to
the size of the total Treg population. Here we describe a
mechanism that may connect previous observations that the
inhibition of Tfr cell expansion by IL-21 was associated with a
decreased expression of CD25 and responsiveness to IL-2.
IL-21-mediated suppression of the a-chain of the high-affinity
IL-2 receptor (CD25) was evident on Tfr cells following SRBC
immunization, as Il21r / Tfr cells expressed CD25 at the high or
maximum levels observed on non-follicular Treg cells. The FoxP3þ
Tfr population comprises both CD25þ and CD25 cells, and we
observed that the CD25þ Tfr population proliferated to a greater
extent in the absence of IL-21:IL-21R interactions. IL-21 reduced
and neutralization of IL-21 improved responsiveness to IL-2 in
CD4þ T cells in vitro and IL-21 was most effective under
conditions of limiting co-stimulation by anti-CD28 monoclonal
antibodies. As one of the major functions of CD28 is to augment
IL-2 production55, these findings are consistent with IL-21 being
less efficient at limiting CD25 expression and Tfr cell expansion
where IL-2 is abundant. Previous studies have demonstrated that
Cd25 is a target of Bcl-6, binding to an intron within Cd25 (ref. 56).
Our findings suggest that other cytokines that can upregulate Bcl-6
may also modulate CD25 expression on Tfr cells. In this regard,
adoptively transferred TCR transgenic Smarta (SM) CD4þ T cells
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Figure 7 | IL-21:IL-21R interactions on Treg cells reduce antigen-specific B-cell responses. FoxP3DTR recipients depleted of FoxP3þ cells on days  1 and
4 of immunization received CD4þ Treg cells purified from the spleens of Il21r/ and WTmice before immunisation with NP-OVA adsorbed to alum.
Localization of (a) FoxP3þ Il21r/ and (b) FoxP3þ WT Tfr cells within GCs of the spleens of Foxp3DTR mice on day 10 of immunization. Histological
sections of spleen were immunostained for IgDþ non-GC B cells (grey scale), FoxP3 (red) and CD4 (green). Individual antibody immunostains are shown
in grey scale. Scale bars, 100 mm. Immunostaining and flow cytometric analyses on day 10 of NP-OVA immunization identified (c) FoxP3þ CD4þ Treg cells
shown as a percentage of CD4þ Tcells in Foxp3DTR mice that received either WT, Il21r/ or no FoxP3 Treg cells (d) FoxP3þ CXCR5þ PD-1þ CD4þ Tfr
cells as a percentage of CD4þ Tcells, (e) the percentage of CD25-expressing cells within the Tfr population, (f) the mean fluorescence intensity of CXCR4
immunostaining on Tfr cells and (g) CXCR5hi Bcl-6þ Tfh cells. Analyses of the GC B-cell populations from the same mice showing the (h) percentage of
FASþ GL7þ GC B cells (i) IgG1þ GC B cells as percentage of B cells and (j) IgG1þ B cells as a percentage of the GC B cell population. (k) Flow cytometry
dot plots showing gating for NP-specific FASþ GC B cells, the (l) percentages of NP-specific (NIPþ) GC B cells and (m) NP-specific IgG1þ GC B cells as a
percentage of B cells. Data are shown as mean±s.d., n¼4 mice with two experimental replicates. P-values were determined by Student’s t-test, P-values
40.05 were deemed not significant (NS).
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and SM Th1 cells retained a notably higher level of CD25
expression in Il6 / recipient mice compared with SM cells in
WT recipients after LCMV infection57. However, our observation
that IL-21:IL-21R signalling had a cell intrinsic role in Tfr cells
suggests that IL-6 does not fully compensate for IL-21 in this
setting. The explanation for this finding remains unknown, but may
reflect the kinetics and localization of IL-21 production during Tfr
cell differentiation and that IL-21 provides multiple inputs,
including the upregulation of Bcl-6 (refs 48,58,59), inhibition of
CD25 expression and destabilization of Foxp3 (refs 27,28).
The relative percentages of Tfh cells in WT and Il21r / mice
reported by our group and others have varied11,60,61, influenced
by the redundant roles of IL-21 and IL-6 in Tfh cell
differentiation40,41. As shown in this study, a contributing
factor to the variations in Tfh cell frequencies in Il21r /
mice may be Il21r / Tfr cells that constitute a greater
proportion of the total CXCR5hiPD-1hi T follicular population
than WT Tfr cells. Although the percentages of Il21r / and
WT Tfh cells were similar, the phenotype of Tfh cells was altered
by Il21r deficiency with a notable increase in CXCR4 expression.
CXCR4 is an a-chemokine receptor specific for stromal-derived-
factor-1 (CXCL12), which is important in haematopoietic
stem cell homing to the BM62 and for sorting of centroblasts
into the GC dark zone45. A previous study has shown that
CXCR4þCXCR5þ double-positive Tfh cells arise following
influenza infection and could be identified within the GC43.
CXCR4þCXCR5þ and CXCR5 single-positive Tfh cells
both provided help for B-cell antibody production in vitro, but
CXCR5 single-positive Tfh cells were superior at inducing
B-cell proliferation43. Within the T-helper populations, IL-21R
deficiency resulted in an expansion of CXCR4þ (CXCR5 )
extrafollicular helper T cells. Il21r / mice harbour increased
levels of IgE63, but whether the expanded CXCR4þ
extrafollicular subset contributes to this effect remains unknown.
The increased ratio of Il21r / Tfr:Tfh cells reinforces the
importance of distinguishing FoxP3 follicular helper and
FoxP3þ follicular Treg cell populations and may contribute to
the important role of IL-21 acting on T cells for humoral
immunity64,65. In this context, we provided evidence that the
increased expansion or differentiation of Il21r / Tfr cells has
functional significance and was associated with a reduction in Tfh
cells, IgG1þ GC B cells and antigen specific IgG1þ B cells and
this finding is in line with previous observations on the influence
of adoptively transferred functionally deficient Tfr cells21. The
presence or absence of IL-21R on donor Treg cells had little
effect on the total GC B cell population and, whilst we observed
slightly reduced antigen specific B cells in FoxP3DTR recipients of
Il21r / Treg cells, the greatest effect was on the broader IgG1þ
population, which is consistent with Tfr cells acting to reduce the
outgrowth of antigen non-specific B-cell clones20.
The propensity for Il21r / T cells to differentiate into Tfr
cells reflects the balance between responsiveness to IL-2 and IL-21
and reinforces the important role for IL-21 in humoral immunity.
The containment of Tfr cells is important for a productive GC
reaction and humoral immune response. Cytokines such as IL-21
that upregulate Bcl-6 have the capacity to reinforce antibody
responses within the GC by constraining CD25 expression and
the subsequent expansion of Tfr cells.
Methods
Patients. Peripheral blood samples of patients, their unaffected first-degree
relatives and healthy volunteers were obtained upon written (parental) consent.
The study protocols were approved by the National Institute of Allergy and
Infectious Diseases Intramural Institutional Review Board in Bethesda, MD,
the Sydney Children’s Hospital Ethics committee and approved according
to the Declaration of Helsinki by the local review board and Ministry of Health
(0306-10-HMO).
Mice. Il21r / mice (created on 129 background and backcrossed onto
C57BL/6ByJ to N12) were kindly provided by Dr Warren Leonard (NIH) and Ly5.1
C57BL/6 congenic mice were purchased from the Animal Research Centre in
Perth, Australia. B6.129(Cg)-Foxp3tm3(DTR/GFP)Ayr/J (Foxp3DTR) mice were kindly
provided by Alexander Rudensky65. The Garvan Institute and St Vincent’s Hospital
Animal Ethics Committee granted permission to perform animal experiments.
Animals were housed under specific pathogen-free conditions and handled in
accordance with the Australian code of practice for the care and use of animals for
scientific purposes. Age-matched littermate mice used for experimental purposes
were between 8 and 10 weeks of age. Conditional Bcl6 / mice on a mixed
C57BL/6–129 Sv background in which CD4þ T cells were made genetically
deficient in Bcl-6 (CD4Cre/WT:BCL6fl/fl) were described previously66.
Immunizations. Mice were immunized (intravenous) with 2 108 sheep red blood
cells (IMVS, Australia) or (intraperitoneal, i.p.) with 100 mg of NP13-OVA absorbed
to alum and spleens analysed at timepoints shown. For adoptive transfer experi-
ments: Treg cells were enriched using the mouse CD4þ CD25þ Regulatory T Cell
Isolation Kit, according to the manufacturer’s instructions (Milentenyi Biotec,
catalogue number 130-091-041). Body weight (50mg kg 1) of diphtheria toxin
was injected to deplete endogenous Treg cells on days  1 and 4 of immunization.
Treg cells (5 105) were transferred into FoxP3DTR mice on day 0 of NP-OVA
immunization. IL-2:IL-2mAb administration: in addition to SRBC immunization,
IL-2:IL-2mAb complexes47,67 were injected i.p. every other day (days 0, 2, 4 and 6)
with JES6-1 monoclonal antibody complexed with IL-2 and immunized i.p. with
2 108 SRBC on day 0, splenocytes were analysed on day 7 via flow cytometry
Bone marrow chimeras. Cohorts of B6 mice were lethally irradiated by a 137Cs
source (B6: two doses of 0.45 Gy 4 h apart) and reconstituted the following day by
intravenous injection with BM cells isolated from femurs and tibiae obtained by
flushing bone with lymphocyte isolation media in sterile conditions. After irra-
diation, mice were maintained on antibiotic water containing cotrimoxazole
(Roche) for 7 days. Irradiated CD45.1 B6 mice were reconstituted with 1 107 BM
cells from Il21rþ /þ mice expressing the congenic markers CD45.2 and CD90.1
(Thy1.1) or CD90.2 (Thy1.2) to allow detection, combined with equal proportions
BM from Thy1.2 CD45.2 WT or Il21r / mice. Our reconstitution protocol
typically resulted in an B40–60:60–40 ratio of WT:Il21r / lymphocytes, and
was contaminated with B10% of endogenous CD45.1þ radio-resistant T cells.
Mice were used for immunization protocols as described above at 8 weeks post
reconstitution.
Immunofluorescence and FACS analyses. For flow cytometric analysis of human
peripheral blood; cells were stained with antibodies directed against surface
molecules and intracellular Foxp3. Antibodies purchased from BD Biosciences
were: anti-CD3-BV786 (SK7, dilution 1/5), anti-CD25-PE (2A3, dilution 1/10),
anti-CD127-BV421 (HIL-7R-M21, dilution 1/20), anti-CXCR5-A647 (RF8B2,
dilution 1/30) and Strepdavidin-BV605 (dilution 1/100); antibodies purchased
from eBioscience were anti-CD4-PE-Cy7 (RPA-T4, dilution 1/20) and anti-PD-1-
biotin (eBioJ105, dilution 1/30). Nuclear Foxp3 was detected with anti-Foxp3-A488
(259D/C7, dilution 1/20) antibody using the eBioscience intracellular staining kit
(catalogue number 00-5523-00) according to the manufacturer’s instructions. For
flow cytometric analysis of mouse lymphocytes; red blood cells were removed by
hypotonic lysis. Fifty microlitres of a single cell suspension at 2 107 cells per ml
from the spleen and lymph nodes were stained in FACS buffer containing
pre-titred antibodies in 96-well V-bottomed microtitre plates (Nunc, Roskilde,
Denmark). Antibodies against surface molecules purchased from BD Bioscience
were anti-CD4-PE-Cy7 (RM4–5, dilution 1/300), anti-CD25-APC & BV605 (PC61,
dilution 1/100), anti-CD45.1-PE-Cy7 (A20, dilution 1/200), anti-CD45.2-APC-Cy7
(104, dilution 1/200), anti-CD90.1-eF450 (HIS51, dilution 1/200), anti-CD90.2-
BV605 (53-2.1, dilution 1/200), anti-CXCR4-PE (2B11/CXCR4, dilution 1/50),
anti-CXCR5-biotin (2G8, dilution 1/100), anti-GL7-PE (GL7, dilution 1/300),
anti-FAS-FITC (Jo2, dilution 1/200), anti-IgG1-biotin (A85-1, dilution 1/100) and
anti-Ki67-A647 (B56, dilution 1/100). Antibodies purchased from eBioscience were
anti-CD19-eF450 (1D3, dilution 1/200), anti-ICOS-PE (C398.4A, dilution 1/300),
anti-PD-1-FITC (RMP1–30, dilution 1/100), Streptavidin-PerCP-Cy5.5 and APC
(dilution 1/300), anti-TCRb-APC, FITC and PerCP-Cy5.5 (H57–597, dilution
1/300). For intracellular immunostaining of CXCR5þ cells, FoxP3 was detected
with the anti-Foxp3-eF450 (FJK-16s, dilution 1/100) antibody purchased from
eBioscience, whereas Bcl-6 was detected using the anti-Bcl-6-PE (112-91, dilution
1/50) antibody purchased from BD Bioscience using the BD intracellular staining
kit (catalogue number 554714) according to the manufacturer’s instructions.
Detection of NP specific B cells was carried out by NIP-PE staining (dilution
1/100), to this end NIP-OSu (Biosearch Technologies) was conjugated to phy-
coerythrin (PE) (Molecular Probes)68. In short, PE was dialysed against 3%
NaHCO3 over night at 4 C, NIP-OSu was diluted in dimethylformamide and
added to PE at a molar ratio of 20:1. The reaction mixture was rotated for 4 h at
room temperature and afterwards dialysed against PBS overnight at 4 C to remove
unconjugated NIP. Intracellular P-STAT5 was detected with anti-P-STAT5-PerCP-
Cy5.5 (47, dilution 1/5) antibody using the BD Phosphlow buffer III (Cat#558050)
according to manufacturer’s instructions. Cells were acquired using either a FACS
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Canto II or a LSRII SORP cytometer (BD Biosciences, CA) and analysed using
Flowjo (Treestar, CA).
Immunohistochemistry. Five-micrometre frozen OCT (Tissue Tek, Australia)
spleen sections were fixed in ice-cold acetone for 8min, washed and incubated with
blocking reagent (Avidin/biotin (Dako)) at room temperature. Primary biotin
or fluorochrome-conjugated antibodies were incubated at room temperature
overnight. Antibodies against surface molecules purchased from BD Biosciences
were anti-CD4-A488 (RM4–5, dilution 1/100) and anti-CD90.2-A647 (53-2.1,
dilution 1/100). CD90.1 was detected using anti-CD90.1-eF450 (HIS51, dilution
1/100) antibody purchased from eBioscience, IgD was detected using anti-IgD-
A488 & A647 (11-26c2a, dilution 1/100) antibodies purchased from Biolegend.
Detection of FoxP3 was performed using TSA Kit 42, with HRP Streptavidin and
Alexa Fluor 555 TyramideT (catalogue number Tx30955, Thermo Fisher) and the
anti-FoxP3-biotin (FJK-16s, dilution 1/100) antibody purchased from eBioscience.
Sections were analysed using a Leica DM I6000 SP8 confocal microscope (Leica
Microsystems, Wetzlar, Germany). The images were processed using the Leica
acquisition and analysis software ImageJ (Freeware NIH, Bethesda, USA) or Adobe
Photoshop, version 7 (San Jose´, CA).
In vitro stimulations. CD4þ T cells were magnetic activated cell sorting (MACS)
enriched from the spleens of WT mice and triplicate samples of 2 106 cells per ml
were preincubated for 5min with or without 5 mgml 1 IL-21RFc and then cul-
tured for 3 days with 0.5 mgml 1 soluble anti-CD3 (clone 145-2C11) and anti-
CD28 (clone 37.51) monoclonal antibody titrated from a starting concentration of
1 mgml 1. IL-21R/Fc chimera used to neutralize IL-21 in vitro was generated in
house69. In brief, the DNA encoding the predicted extracellular domain (aa 1–235)
of mouse IL-21R with a GSGS linker were amplified by PCR, and linked to mIgG2a
Fc. The Fc domain contains four amino acid mutations (L285E, E368A, K370A and
K372A) to minimize Fc binding and complement fixation. The resulting construct
was subcloned into pEE12.4 (Lonza), a mammalian glutamine synthase expression
vector, transfected into Chinese hamster ovary-K1SV cells, and grown in
the presence of 25 mmol l 1 methionine sulphoximine. Following protein A
purification, purity of IL-21R/Fc was checked by SDS–PAGE (Coomassie blue
staining and silver stain, Lonza) and tested for presence of endotoxin (Lonza).
In vitro BAF-3 proliferation assay measuring biological activity of IL-21R/Fc
construct was conducted. For in vitro experiments using Bcl-6-deficient CD4þ
T cells; CD4þ T cells were MACS enriched from the spleen of WT (WT/
WT:BCL6fl/fl) and Bcl6 conditional knockout mice (CD4Cre/WT:BCL6fl/fl) mice
and triplicate samples of 2 106 cells per ml were preincubated for 5min with or
without 5 mgml 1 IL-21RFc and then cultured for 3 days with 0.5 mgml 1 soluble
anti-CD3 monoclonal antibody with or without 0.031 mgml 1 anti-CD28
monoclonal antibody in the presence or absence of rmIL-21 (RnD Systems or made
in house70). Following culture, live cells were immunostained and analysed by flow
cytometry.
Treg cell conversion in vitro. CD4þ cells were isolated from splenocytes
by positive selection using magnetic beads. The CD4-negative fractions were
irradiated with 3,000 rad and used as antigen presenting cells. To induce Treg
cell conversion, CD4þ T cells were activated in the presence of 3 ngml 1
recombinant human transforming growth factor-b1 with 1 mgml 1 anti-CD3
monoclonal antibody (clone 145-2C11), either soluble in the presence of antigen
presenting cells, or plate-bound together with soluble 2 mgml 1 anti-CD28
monoclonal antibody (clone 37.51). Conversion efficiency was assessed by flow
cytometry on day 3 after surface staining for CD4 and 7-aminoactinomycin D
(7-AAD) followed by intracellular staining for Foxp3.
Statistics. P-values between data sets were determined by two-tailed Student’s
t-test, assuming equal variance or one-way analysis of variance where indicated.
Mixed BM chimeras were analysed in individual mice by pairwise analyses (t-test).
Data availability. The authors declare that the data supporting the findings of this
study are available within the article and its Supplementary Information files.
References
1. Zhernakova, A., van Diemen, C. C. & Wijmenga, C. Detecting shared
pathogenesis from the shared genetics of immune-related diseases. Nat. Rev.
Genet. 10, 43–55 (2009).
2. Richard-Miceli, C. & Criswell, L. A. Emerging patterns of genetic overlap across
autoimmune disorders. Genome Med. 4, 6 (2012).
3. Parrish-Novak, J. et al. Interleukin 21 and its receptor are involved in NK cell
expansion and regulation of lymphocyte function. Nature 408, 57–63 (2000).
4. Parrish-Novak, J., Foster, D. C., Holly, R. D. & Clegg, C. H. Interleukin-21 and
the IL-21 receptor: novel effectors of NK and T cell responses. J. Leukoc. Biol.
72, 856–863 (2002).
5. Sadlack, B. et al. Ulcerative colitis-like disease in mice with a disrupted
interleukin-2 gene. Cell 75, 253–261 (1993).
6. Willerford, D. M. et al. Interleukin-2 receptor alpha chain regulates the size and
content of the peripheral lymphoid compartment. Immunity 3, 521–530 (1995).
7. Fontenot, J. D., Rasmussen, J. P., Gavin, M. A. & Rudensky, A. Y. A function
for interleukin 2 in Foxp3-expressing regulatory T cells. Nat. Immunol. 6,
1142–1151 (2005).
8. Bennett, C. L. et al. The immune dysregulation, polyendocrinopathy,
enteropathy, X-linked syndrome (IPEX) is caused by mutations of FOXP3. Nat.
Genet. 27, 20–21 (2001).
9. Rochman, Y., Spolski, R. & Leonard, W. J. New insights into the regulation of
T cells by gamma(c) family cytokines. Nat. Rev. Immunol. 9, 480–490 (2009).
10. King, C., Tangye, S. G. & Mackay, C. R. T follicular helper (TFH) cells in normal
and dysregulated immune responses. Annu. Rev. Immunol. 26, 741–766 (2008).
11. Vogelzang, A. et al. A fundamental role for interleukin-21 in the generation of
T follicular helper cells. Immunity 29, 127–137 (2008).
12. Ozaki, K., Kikly, K., Michalovich, D., Young, P. R. & Leonard, W. J. Cloning of
a type I cytokine receptor most related to the IL-2 receptor beta chain. Proc.
Natl Acad. Sci. USA 97, 11439–11444 (2000).
13. Leonard, W. J., Zeng, R. & Spolski, R. Interleukin 21: a cytokine/cytokine
receptor system that has come of age. J. Leukoc. Biol. 84, 348–356 (2008).
14. Elsaesser, H., Sauer, K. & Brooks, D. G. IL-21 is required to control chronic
viral infection. Science 324, 1569–1572 (2009).
15. Yi, J. S., Du, M. & Zajac, A. J. A vital role for interleukin-21 in the control of a
chronic viral infection. Science 324, 1572–1576 (2009).
16. Kotlarz, D. et al. Loss-of-function mutations in the IL-21 receptor gene cause a
primary immunodeficiency syndrome. J. Exp. Med. 210, 433–443 (2013).
17. Kotlarz, D., Zietara, N., Milner, J. D. & Klein, C. Human IL-21 and IL-21R
deficiencies: two novel entities of primary immunodeficiency. Curr. Opin.
Pediatr. 26, 704–712 (2014).
18. Salzer, E. et al. Early-onset inflammatory bowel disease and common variable
immunodeficiency-like disease caused by IL-21 deficiency. J. Allergy Clin.
Immunol. 133, 1651–1659.e12 (2014).
19. Stepensky, P. et al. Extending the clinical and immunological phenotype of
human interleukin-21 receptor deficiency. Haematologica 100, e72–e76 (2015).
20. Linterman, M. A. et al. Foxp3þ follicular regulatory T cells control the
germinal center response. Nat. Med. 17, 975–982 (2011).
21. Chung, Y. et al. Follicular regulatory T cells expressing Foxp3 and Bcl-6
suppress germinal center reactions. Nat. Med. 17, 983–988 (2011).
22. Wollenberg, I. et al. Regulation of the germinal center reaction by
Foxp3þ follicular regulatory T cells. J. Immunol. 187, 4553–4560 (2011).
23. Ansel, K. M., McHeyzer-Williams, L. J., Ngo, V. N., McHeyzer-Williams, M. G.
& Cyster, J. G. In vivo-activated CD4 T cells upregulate CXC chemokine
receptor 5 and reprogram their response to lymphoid chemokines. J. Exp. Med.
190, 1123–1134 (1999).
24. Delgoffe, G. M. & Vignali, D. A. STAT heterodimers in immunity: a mixed
message or a unique signal? JAKSTAT 2, e23060 (2013).
25. Attridge, K. et al. IL-21 inhibits T cell IL-2 production and impairs Treg
homeostasis. Blood 119, 4656–4664 (2012).
26. Schmitz, I. et al. IL-21 restricts virus-driven Treg cell expansion in chronic
LCMV infection. PLoS Pathog. 9, e1003362 (2013).
27. Nurieva, R. et al. Essential autocrine regulation by IL-21 in the generation of
inflammatory T cells. Nature 448, 480–483 (2007).
28. Korn, T. et al. IL-21 initiates an alternative pathway to induce proinflammatory
T(H)17 cells. Nature 448, 484–487 (2007).
29. Clough, L. E. et al. Release from regulatory T cell-mediated suppression during
the onset of tissue-specific autoimmunity is associated with elevated IL-21.
J. Immunol. 180, 5393–5401 (2008).
30. Li, Y. & Yee, C. IL-21 mediated Foxp3 suppression leads to enhanced
generation of antigen-specific CD8þ cytotoxic T lymphocytes. Blood 111,
229–235 (2008).
31. Ballesteros-Tato, A. et al. Interleukin-2 inhibits germinal center formation
by limiting T follicular helper cell differentiation. Immunity 36, 847–856
(2012).
32. Nurieva, R. I. et al. STAT5 protein negatively regulates T follicular helper (Tfh)
cell generation and function. J. Biol. Chem. 287, 11234–11239 (2012).
33. Johnston, R. J., Choi, Y. S., Diamond, J. A., Yang, J. A. & Crotty, S. STAT5 is a
potent negative regulator of TFH cell differentiation. J. Exp. Med. 209, 243–250
(2012).
34. Oestreich, K. J., Mohn, S. E. & Weinmann, A. S. Molecular mechanisms that
control the expression and activity of Bcl-6 in TH1 cells to regulate flexibility
with a TFH-like gene profile. Nat. Immunol. 13, 405–411 (2012).
35. Seddiki, N. et al. Expression of interleukin (IL)-2 and IL-7 receptors
discriminates between human regulatory and activated T cells. J. Exp. Med. 203,
1693–1700 (2006).
36. Liu, W. et al. CD127 expression inversely correlates with FoxP3 and suppressive
function of human CD4þ T reg cells. J. Exp. Med. 203, 1701–1711 (2006).
37. Sage, P. T., Francisco, L. M., Carman, C. V. & Sharpe, A. H. The receptor PD-1
controls follicular regulatory T cells in the lymph nodes and blood. Nat.
Immunol. 14, 152–161 (2013).
NATURE COMMUNICATIONS | DOI: 10.1038/ncomms14647 ARTICLE
NATURE COMMUNICATIONS | 8:14647 |DOI: 10.1038/ncomms14647 | www.nature.com/naturecommunications 13
38. Sage, P. T., Alvarez, D., Godec, J., von Andrian, U. H. & Sharpe, A. H.
Circulating T follicular regulatory and helper cells have memory-like
properties. J. Clin. Invest. 124, 5191–5204 (2014).
39. Ma, C. S. et al. Monogenic mutations differentially affect the quantity and
quality of T follicular helper cells in patients with human primary
immunodeficiencies. J. Allergy Clin. Immunol. 136, 993–1006.e1 (2015).
40. Eto, D. et al. IL-21 and IL-6 are critical for different aspects of B cell immunity
and redundantly induce optimal follicular helper CD4 T cell (Tfh)
differentiation. PLoS ONE 6, e17739 (2011).
41. Karnowski, A. et al. B and T cells collaborate in antiviral responses via IL-6,
IL-21, and transcriptional activator and coactivator, Oct2 and OBF-1. J. Exp.
Med. 209, 2049–2064 (2012).
42. Odegard, J. M. et al. ICOS-dependent extrafollicular helper T cells elicit IgG
production via IL-21 in systemic autoimmunity. J. Exp. Med. 205, 2873–2886
(2008).
43. Elsner, R. A., Ernst, D. N. & Baumgarth, N. Single and coexpression of CXCR4
and CXCR5 identifies CD4 T helper cells in distinct lymph node niches during
influenza virus infection. J. Virol. 86, 7146–7157 (2012).
44. Kroenke, M. A. et al. Bcl6 and Maf cooperate to instruct human follicular
helper CD4 T cell differentiation. J. Immunol. 188, 3734–3744 (2012).
45. Allen, C. D. et al. Germinal center dark and light zone organization is mediated
by CXCR4 and CXCR5. Nat. Immunol. 5, 943–952 (2004).
46. Boyman, O., Kovar, M., Rubinstein, M. P., Surh, C. D. & Sprent, J. Selective
stimulation of T cell subsets with antibody-cytokine immune complexes.
Science 311, 1924–1927 (2006).
47. Liu, X. et al. Bcl6 expression specifies the T follicular helper cell program
in vivo. J. Exp. Med. 209, 1841–1852 (2012).
48. Nurieva, R. I. et al. Bcl6 mediates the development of T follicular helper cells.
Science 325, 1001–1005 (2009).
49. Liao, W., Lin, J. X., Wang, L., Li, P. & Leonard, W. J. Modulation of cytokine
receptors by IL-2 broadly regulates differentiation into helper T cell lineages.
Nat. Immunol. 12, 551–559 (2011).
50. Luthje, K. et al. The development and fate of follicular helper T cells defined by
an IL-21 reporter mouse. Nat. Immunol. 13, 491–498 (2012).
51. Jandl, C. & King, C. Cytokines in the germinal center niche. Antibodies 5, 5
(2016).
52. Ndhlovu, L. C., Loo, C. P., Spotts, G., Nixon, D. F. & Hecht, F. M. FOXP3
expressing CD127lo CD4þ T cells inversely correlate with CD38þ CD8þ
T cell activation levels in primary HIV-1 infection. J. Leukoc. Biol. 83, 254–262
(2008).
53. Piao, W. H. et al. IL-21 modulates CD4þ CD25þ regulatory T-cell
homeostasis in experimental autoimmune encephalomyelitis. Scand. J.
Immunol. 67, 37–46 (2008).
54. Ding, Y. et al. Interleukin-21 promotes germinal center reaction by skewing the
follicular regulatory T cell to follicular helper T cell balance in autoimmune
BXD2 mice. Arthritis Rheumatol. 66, 2601–2612 (2014).
55. Riley, J. L. & June, C. H. The CD28 family: a T-cell rheostat for therapeutic
control of T-cell activation. Blood 105, 13–21 (2005).
56. Hatzi, K. et al. BCL6 orchestrates Tfh cell differentiation via multiple distinct
mechanisms. J. Exp. Med. 212, 539–553 (2015).
57. Choi, Y. S., Eto, D., Yang, J. A., Lao, C. & Crotty, S. Cutting edge: STAT1 is
required for IL-6-mediated Bcl6 induction for early follicular helper cell
differentiation. J. Immunol. 190, 3049–3053 (2013).
58. Johnston, R. J. et al. Bcl6 and Blimp-1 are reciprocal and antagonistic regulators
of T follicular helper cell differentiation. Science 325, 1006–1010 (2009).
59. Yu, D. et al. The transcriptional repressor Bcl-6 directs T follicular helper cell
lineage commitment. Immunity 31, 457–468 (2009).
60. Linterman, M. A. et al. IL-21 acts directly on B cells to regulate Bcl-6 expression
and germinal center responses. J. Exp. Med. 207, 353–363 (2010).
61. Zotos, D. et al. IL-21 regulates germinal center B cell differentiation and
proliferation through a B cell-intrinsic mechanism. J. Exp. Med. 207, 365–378
(2010).
62. Ma, Q., Jones, D. & Springer, T. A. The chemokine receptor CXCR4 is required
for the retention of B lineage and granulocytic precursors within the bone
marrow microenvironment. Immunity 10, 463–471 (1999).
63. Ozaki, K. et al. A critical role for IL-21 in regulating immunoglobulin
production. Science 298, 1630–1634 (2002).
64. Rasheed, M. A. et al. Interleukin-21 is a critical cytokine for the generation of
virus-specific long-lived plasma cells. J. Virol. 87, 7737–7746 (2013).
65. McGuire, H. M. et al. IL-21 and IL-4 collaborate to shape T-dependent
antibody responses. J. Immunol. 195, 5123–5135 (2015).
66. Kim, J. M., Rasmussen, J. P. & Rudensky, A. Y. Regulatory T cells prevent
catastrophic autoimmunity throughout the lifespan of mice. Nat. Immunol. 8,
191–197 (2007).
67. Hollister, K. et al. Insights into the role of Bcl6 in follicular Th cells using a new
conditional mutant mouse model. J. Immunol. 191, 3705–3711 (2013).
68. Wolniak, K. L., Noelle, R. J. & Waldschmidt, T. J. Characterization of
(4-hydroxy-3-nitrophenyl)acetyl (NP)-specific germinal center B cells and
antigen-binding B220- cells after primary NP challenge in mice. J. Immunol.
177, 2072–2079 (2006).
69. McGuire, H. M. et al. Loss of parity between IL-2 and IL-21 in the NOD Idd3
locus. Proc. Natl Acad. Sci. USA (2009).
70. Lee, C. M., McGuire, H., Basten, A., King, C. & Christ, D. Expression,
purification and characterization of recombinant interleukin-21. J. Immunol.
Methods 362, 185–189 (2010).
Acknowledgements
We thank Drs Cindy Ma and Stuart Tangye for their help with human samples. This
work was supported by grants from the Diabetes Australia Research Trust and the
National Health and Medical Research Council.
Author contributions
C.J. performed mouse and human experiments and statistical analyses, and edited
the manuscript. S.M.L. performed experiments, statistical analyses and edited the
manuscript. P.F.C., J.W., W.E.H., A.V. and K.W. performed and assisted experiments.
M.E.C., G.U., P.S., B.K. and K.W. prepared and provided human tissues and edited
sections of the manuscript. A.D. and J.S. provided reagents. C.K. oversaw analyses, wrote
and edited the final manuscript.
Additional information
Supplementary Information accompanies this paper at http://www.nature.com/
naturecommunications
Competing financial interests: The authors declare no competing financial interests.
Reprints and permission information is available online at http://npg.nature.com/
reprintsandpermissions/
How to cite this article: Jandl, C. et al. IL-21 restricts T follicular regulatory T cell
proliferation through Bcl-6 mediated inhibition of responsiveness to IL-2. Nat. Commun.
8, 14647 doi: 10.1038/ncomms14647 (2017).
Publisher’s note: Springer Nature remains neutral with regard to jurisdictional claims in
published maps and institutional affiliations.
This work is licensed under a Creative Commons Attribution 4.0
International License. The images or other third party material in this
article are included in the article’s Creative Commons license, unless indicated otherwise
in the credit line; if the material is not included under the Creative Commons license,
users will need to obtain permission from the license holder to reproduce the material.
To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/
r The Author(s) 2017
ARTICLE NATURE COMMUNICATIONS | DOI: 10.1038/ncomms14647
14 NATURE COMMUNICATIONS | 8:14647 |DOI: 10.1038/ncomms14647 | www.nature.com/naturecommunications
